Consun

Consun Pharmaceutical Group is a modern pharmaceutical enterprise integrating research and development, production, and marketing. Established in 1997, it was listed in Hong Kong in 2013. Consun Pharmaceutical Group has four production bases in China, located in Guangzhou of Guangdong, Tongliao of Inner Mongolia, Yulin of Guangxi, and Horgos of Xinjiang, with over 3,000 employees. The group focuses on nephrology as its flagship area while promoting imaging, gynecology and pediatrics, orthopedics, dermatology, hepatobiliary, and gastroenterology product lines. It possesses a rich product portfolio and continuously engages in technological innovation and new product development. Currently, it offers 138 varieties, including 62 traditional Chinese medicine products and 76 Western medicine products, of which 33 varieties are included in the National Essential Drug List and 67 varieties are included in the National Medical Insurance Catalog. In 2010, Zhenggu Water was awarded the status of "National Geographical Indication Protected Product." The company also has a highly specialized marketing team covering both hospital and OTC sectors, with a distribution network spread across China. The company’s operating performance has maintained long-term stable and rapid growth.